Is Rockwell Medical Stock a Good Investment?
Rockwell Medical Investment Advice | RMTI |
- Examine Rockwell Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Rockwell Medical's leadership team and their track record. Good management can help Rockwell Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Rockwell Medical's business and its evolving consumer preferences.
- Compare Rockwell Medical's performance and market position to its competitors. Analyze how Rockwell Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Rockwell Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Rockwell Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Rockwell Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Rockwell Medical is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Inconclusive | Details |
Examine Rockwell Medical Stock
Researching Rockwell Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Rockwell Medical was at this time reported as 0.73. The company recorded a loss per share of 0.04. Rockwell Medical had not issued any dividends in recent years. The entity had 1:11 split on the 13th of May 2022.
To determine if Rockwell Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Rockwell Medical's research are outlined below:
| Rockwell Medical generated a negative expected return over the last 90 days | |
| Rockwell Medical has high historical volatility and very poor performance | |
| Rockwell Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 83.61 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 4.08 M. | |
| Rockwell Medical currently holds about 27.56 M in cash with (9.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rockwell Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Insider Sell Cyril Perducat Sells Shares of Rockwell Automation Inc |
Rockwell Medical Quarterly Good Will |
|
Rockwell Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Rockwell Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Rockwell Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Rockwell Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Rockwell Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-14 | 2024-03-31 | -0.04 | -0.06 | -0.02 | 50 | ||
2024-03-21 | 2023-12-31 | -0.07 | -0.05 | 0.02 | 28 | ||
2023-11-14 | 2023-09-30 | -0.1 | -0.07 | 0.03 | 30 | ||
2024-11-11 | 2024-09-30 | 0.01 | 0.0441 | 0.0341 | 341 | ||
2024-08-08 | 2024-06-30 | -0.04 | 0.01 | 0.05 | 125 | ||
2023-08-14 | 2023-06-30 | -0.12 | -0.18 | -0.06 | 50 | ||
2023-05-15 | 2023-03-31 | -0.16 | -0.1 | 0.06 | 37 | ||
2022-11-14 | 2022-09-30 | -0.48 | -0.4 | 0.08 | 16 |
Know Rockwell Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Rockwell Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rockwell Medical backward and forwards among themselves. Rockwell Medical's institutional investor refers to the entity that pools money to purchase Rockwell Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bailard Inc | 2024-09-30 | 72.8 K | Northern Trust Corp | 2024-09-30 | 63.4 K | Hillsdale Investment Management Inc. | 2024-09-30 | 60.8 K | Cubist Systematic Strategies, Llc | 2024-09-30 | 57.2 K | Algert Global Llc | 2024-09-30 | 50.9 K | Millennium Management Llc | 2024-06-30 | 47.8 K | Wealthtrust Axiom Llc | 2024-09-30 | 38 K | Baader Bank Inc | 2024-09-30 | 35.8 K | Hightower Advisors, Llc | 2024-06-30 | 32.7 K | Armistice Capital, Llc | 2024-09-30 | 3.6 M | Vanguard Group Inc | 2024-09-30 | 1.2 M |
Rockwell Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 71.75 M.Market Cap |
|
Rockwell Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.19) | (0.20) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.40) | (0.42) |
Determining Rockwell Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Rockwell Medical is a good buy. For example, gross profit margin measures Rockwell Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Rockwell Medical's profitability and make more informed investment decisions.
Rockwell Medical's Earnings Breakdown by Geography
Evaluate Rockwell Medical's management efficiency
Rockwell Medical has return on total asset (ROA) of (0.0425) % which means that it has lost $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.289) %, meaning that it created substantial loss on money invested by shareholders. Rockwell Medical's management efficiency ratios could be used to measure how well Rockwell Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.22. The current Return On Capital Employed is estimated to decrease to -0.2. As of now, Rockwell Medical's Total Current Assets are increasing as compared to previous years. The Rockwell Medical's current Intangible Assets is estimated to increase to about 13 M, while Total Assets are projected to decrease to under 37.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.91 | 0.87 | |
| Tangible Book Value Per Share | 0.41 | 0.39 | |
| Enterprise Value Over EBITDA | (10.34) | (10.86) | |
| Price Book Value Ratio | 2.07 | 1.97 | |
| Enterprise Value Multiple | (10.34) | (10.86) | |
| Price Fair Value | 2.07 | 1.97 | |
| Enterprise Value | 48.5 M | 88.2 M |
Understanding the operational decisions made by Rockwell Medical management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 1.503 |
Basic technical analysis of Rockwell Stock
As of the 29th of November, Rockwell Medical holds the Coefficient Of Variation of (3,246), risk adjusted performance of (0.01), and Variance of 48.14. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rockwell Medical, as well as the relationship between them.Rockwell Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rockwell Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rockwell Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rockwell Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Strobeck over a month ago Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 3.6852 subject to Rule 16b-3 | ||
Megan Timmins over six months ago Disposition of 3137 shares by Megan Timmins of Rockwell Medical at 1.4 subject to Rule 16b-3 | ||
Skibsted Russell over a year ago Acquisition by Skibsted Russell of 80000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Yocum Richard C over a year ago Acquisition by Yocum Richard C of 100000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Smiley Andrea Heslin over a year ago Acquisition by Smiley Andrea Heslin of 24715 shares of Rockwell Medical subject to Rule 16b-3 |
Rockwell Medical's Outstanding Corporate Bonds
Rockwell Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rockwell Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rockwell bonds can be classified according to their maturity, which is the date when Rockwell Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Rockwell Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Rockwell Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 4.3 | |||
| Coefficient Of Variation | (3,246) | |||
| Standard Deviation | 6.94 | |||
| Variance | 48.14 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (1.27) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 57.6 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 8.18 | |||
| Skewness | (2.39) | |||
| Kurtosis | 15.06 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 4.3 | |||
| Coefficient Of Variation | (3,246) | |||
| Standard Deviation | 6.94 | |||
| Variance | 48.14 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (1.27) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 57.6 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 8.18 | |||
| Skewness | (2.39) | |||
| Kurtosis | 15.06 |
Consider Rockwell Medical's intraday indicators
Rockwell Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rockwell Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 14427.28 | |||
| Daily Balance Of Power | 0.875 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 2.25 | |||
| Day Typical Price | 2.26 | |||
| Price Action Indicator | 0.075 | |||
| Period Momentum Indicator | 0.07 |
Rockwell Medical Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Rockwell Stock media impact
Far too much social signal, news, headlines, and media speculation about Rockwell Medical that are available to investors today. That information is available publicly through Rockwell media outlets and privately through word of mouth or via Rockwell internal channels. However, regardless of the origin, that massive amount of Rockwell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Rockwell Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Rockwell Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Rockwell Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Rockwell Medical alpha.
Rockwell Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Rockwell Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Rockwell Medical Corporate Management
| Megan Timmins | Chief VP | Profile | |
| David Kull | Principal Accounting Officer | Profile | |
| Jason Finkelstein | Investor Representative | Profile | |
| Marc MD | Chief Officer | Profile | |
| Jesse Neri | Senior Finance | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share 3.041 | Quarterly Revenue Growth 0.429 | Return On Assets (0.04) | Return On Equity (0.29) |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Rockwell Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.